#34 Veterinary pharmacovigilance, part 1 – James Mount

#34 Veterinary pharmacovigilance, part 1 – James Mount

47 Minuten

Beschreibung

vor 1 Jahr

Human and veterinary pharmacovigilance (PV) share many goals,
challenges and approaches. But there are also significant
differences, such as the numerous species and breeds that
veterinary PV needs to take into account. In this two-part
episode of Drug Safety Matters, James Mount, Veterinary
Pharmacovigilance assessor at the Swedish Medical Products
Agency, and EU elected chair of the Pharmacovigilance Working
Party for veterinary medicinal products, joins the show to talk
about veterinary PV practice and its differences and similarities
to human PV. 
 


Tune in to find out:


What are the similarities and differences between veterinary
and human pharmacovigilance?

How is animal health connected to public health? 

What types of adverse events are reported on the veterinary
side compared with the human side? 

What can be found in the EU veterinary pharmacovigilance
database? 



 


Want to know more?


The new veterinary medicines regulation (Regulation (EU)
2019/6) can be found here. 

The public portal of the European Union Veterinary
Pharmacovigilance Database.

WHO's information page on One Health, an integrated approach
to the well-being of people, animals and the environment.

A survey of veterinary professionals in Sweden, about current
practices and attitudes in relation to adverse events reporting
and the accessibility of product safety information.

A review of adverse events in animals and children after
secondary exposure to transdermal hormone-containing medicinal
products. 

A study looking at suspected adverse drug reaction reporting
in veterinary free‐text clinical narratives.

The EMA Big Data strategy for veterinary medicines in the
EU. 

Data quality framework for medicines regulation | European
Medicines Agency (EMA)

Small Animal Veterinary Surveillance Network (SAVSNET) -
University of Liverpool

VetCompass - Royal Veterinary College, RVC

Reflection paper on the use of artificial intelligence in the
lifecycle of medicines | European Medicines Agency (EMA)

The Swedish Medical Products Agency's online reporting form
for suspected adverse drug reactions in animals (In Swedish).
 






Join the conversation on social mediaFollow us on
Facebook, LinkedIn, X, or Bluesky and share your thoughts about
the show with the hashtag #DrugSafetyMatters.

Got a story to share?We’re always looking for new
content and interesting people to interview. If you have a great
idea for a show, get in touch!

About UMCRead more about Uppsala Monitoring Centre
and how we work to advance medicines safety.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15